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Slln'lmar~ 
Using cytotoxic T  lymphocyte (CTL) responses to the dass I histocompatibility antigen Qal 
and to the minor histocompatibility antigen H-Y, we show that the immune system maintains 
a peripheral screening process that is able to tolerize a wide variety of potentially autoimmune 
CTL. The critical factor is the presence or absence of specific T helper cells. If T help is available, 
CTL precursors that recognize antigen are activated. In the absence of help, they are tolerized. 
Thus, T  helper cells  are guardians of peripheral tolerance in CTL. 
lthough the first step in the induction of T cell tolerance 
occurs in the thymus, where newly arising autoreactive 
T cells are inactivated (1-7), four sorts of autoreactive T cells 
potentially exist in the periphery: rare "escapees" from thymic 
deletion, newly autoreactive cells arising by mutation (8, 9), 
T cells developed outside the thymus (10, 11) and T cells recog- 
nizing tissue-specific peripheral antigens that may be under- 
represented in the thymus. To deal with this last category, 
which has been seen in mice, chickens, and frogs expressing 
an antigen only on a peripheral organ (12-21), we had sug- 
gested (22) that antigens may be transported to the thymus 
by circulating APC. However, since acquired antigens are more 
efficiently presented in association with MHC class II than 
class I molecules (23), tolerizing to peripheral antigens may 
be much more effective for CD4 + than for CD8 + T  cells. 
How then are CD8 + CTL prevented from reacting to pe- 
ripheral antigens? 
22 yr ago, Bretscher and Cohn (24) proposed a two-signal 
model of activation for B cells, designed to maintain periph- 
eral tolerance in the face of somatic hypermutation. They sug- 
gested that B cells received one signal from the antigen and 
a second from a helper cell specific for the same or a linked 
antigen, and that tolerance would result from the perception 
of signal one without signal two. Recently, several studies 
suggested that both B cell and CTL tolerance may be main- 
tained this way. For example, mice primed in the absence 
of help were subsequently unable to reject Qal-bearing grafts 
(19),  generate specific CTL to Qal (19, 25) or H-Y (25), or 
produce antibody responses to protein antigens (26,  27). 
Although these results were interpreted in the context of 
the two-signal model, other mechanisms are possible.  Here 
we have analyzed a variety of potential mechanisms and found 
that the recognition of antigen in the absence of help is in- 
deed a tolerogenic event for CTL, whether they be thymo- 
cytes or mature peripheral lymphocytes. 
Materials and Methods 
Mice.  C57BL/6  (H-2 b, Qal  b) and BALB/c (H-2 d, Qal b) mice 
were from Iffa-Credo (EArbresle, France), BALB.B (H-2  b, Qal  b) 
and B6.TIa* (H-2  b, QaP) mice were from Olac (Bicester, England), 
and A.Tla  b (H-2*, Qal  b) mice were bred in our facility (Kaiser- 
angst,  Switzerland). 
In  Vitr  Immunization.  Mice  were  immunized by  an  in- 
traperitoneal injection of 107 splenocytes (prepared in serum-free 
medium) unless otherwise specified. 
T Cell Depletion.  Spleen  cells were panned on petri dishes that 
had been coated with a mixture of T cell-specific mAbs: J1J, 100 
/~g/ml (anti-Thy-1; 28); YTS 169.4, 20/zg/ml (anti-CD8; 27); and 
GK1.5, 10/zg/ml (anti-CD4;  29), and then further depleted by 
two-step complement lysis with these mAbs and 10% rabbit com- 
plement (Low Tox-M; Cedarlane Laboratories, Homby, Canada) 
followed by passage over Ficoll-Paque  |  (Pharmacia Fine Chemicals, 
Piscataway, NJ). 
Anti-CD4 Depletion In Viva  Mice  were injected intraperitoneaUy 
twice, 36 and 12 h before priming with 1 mg of GK1.5 and 0.1 
mg YTA 3.1.2 (30), two synergistic anti-CD4 mAbs. FACS  |  anal- 
ysis (Becton Dickinson & Co., Mountain View, CA) revealed  that 
CD4 + cells were completely depleted in the spleen and lymph 
nodes.  Thymocytes,  though coated with  the mAbs  were  not 
depleted. Repopulation  with CD4 + cells began after 1 wk and 
was complete at "~8 wk. 
Medium and Supplements.  Cultures were set up in IMDM con- 
taining 10% FCS, 6  x  10 -s M a-thyoglycerol,  and 50/~g/ml gen- 
tamycin. CAS, used in thymocyte cultures, was a supernatant of 
rat spleen cells activated for 48 h by 5/zg/ml of Con A. 
In Vitro MLR and CTL Cultures.  4  x  106 spleen cells or 9  x 
106 thymocytes were stimulated in 2-ml cultures for 5 d with 2 
x  106 or for 7 d with 7  x  106 irradiated (3,000 rad) stimulator 
spleen cells, respectively. 10% Con A supernatant (CAS)  1 (plus 10 
mM c~-methyl-mannoside)  was added to thymocyte cultures as a 
source of helper factors. Serial 3x dilutions of cultured responders 
1 Abbreviation used in this  paper: CAS, Con A supernatant; P,./T, responder 
to target. 
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in a 3.5-h assay. Responder to target (R/T) ratio, shown as re- 
sponder dilution, is calculated from the number of responders ini- 
tially cultured. Spontaneous release  was done in the absence  of kilhr 
cells and maximal release  was induced with Zaponin (Zap/O/globin; 
Coulter Electronics, Luton, England). Percent specific  lysis equals: 
100 x  (experimental release -  spontaneous release)/(maximal re- 
lease  -  spontaneous release). 
Summary Figures.  Each point represents the specific  lysis gener- 
ated by spleen cells from an individual mouse at an R/T ratio cor- 
responding to the point, in each experiment, where the responses 
of the control mice drop off the plateau. 
Data are presented according to Tufte (31). 
PLesIllts 
A  Hapten-Carrier System for Cytotoxic T  Cells 
To study the effects of signal one on CTL activity, we used 
the response of B6.TIa ~ (B6') mice to the MHC class I an- 
tigen Qal (32, 33), an experimental system described by Keene 
and Porman (34) in which the CTL response shares  many 
characteristics with the hapten-carrier systems used to study 
T-B ceU interactions. Unlike other class I molecules, Qal does 
not usually elicit primary CTL responses in vitro (35-37), 
and, with rare exceptions (37-39),  it does not act as a res- 
tricting element. In fact, in H-2  b mice, Qal elicits CTL re- 
sponses  only when coupled with a carrier antigen able to 
activate T cell help, a defect that may result from its inability 
to couple well enough with A b to dicit strong CD4 + helper 
responses. 
This hapten-like character of Qal is illustrated in Fig.  1 
by the responses of B6' mice to B6,  two congenic strains 
carrying different Qal alleles (31). Fig.  1 a shows that un- 
primed B6' mice (which are Qa-1 = [40]) generate very weak 
CTL responses to B6 (which are Qa-lb),  and mice primed 
in vivo with B6 cells do no better (Fig.  1 b). However, mice 
primed with B6 male cells (bearing Qa-1 b plus H-Y) respond 
well in vitro to B6 female cells (Fig. 1 c), revealing the carrier 
effect of H-Y. This carrier effect is seen only if Qal and H-Y 
are expressed by the same cell (data not shown, and 34),  a 
form of hapten-carrier linkage (41). Fig. 1 d shows that the 
minor histocompatibility antigens of BALB.B can also serve 
as carrier antigens, indicating that Qal, like typical haptens, 
can be linked to many different kinds of carriers (41). 
Fig. 1, e-h shows that in vivo priming depends on the pres- 
ence of CD4 + T helper cells. We depleted female B6' mice 
of peripheral CD4 + T cells, injected them with male or fe- 
male spleen cells bearing Qal b, and 12 wk later, when they 
had replenished their helper cells,  tested them for in vitro 
CTL responses.  The mice that had been primed during the 
CD4-depleted  period  were  totally  unresponsive  to  Qal, 
whether they had been primed with Qal alone (Fig.  l f), 
or Qal plus H-Y (h). Thus, CD4 + T helper cells are essen- 
tial for in vivo priming to Qal. 
They are also necessary for the in vitro boost. Although 
primed CTL precursors do not need carrier antigens in vitro 
(Fig.  1 d), they do need CD4 + T helper cells (42, 43). Our 
interpretation for this paradox is that B6' mice may have a 
few T helpers able to see Qalb; too few to generate a strong 
primary CTL response but,  either because of expansion or 
a change of state,  enough to help a secondary response. In 
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Figure 1.  Cytotoxic T cells spe- 
cific for Qal need T cell help. (Tbp) 
The cytotoxic responses of B6' fe- 
male mice primed to Qal, alone or 
coupled  with  various  carrier  an- 
tigens.  (Bottom) The responses of 
mice  that  were  primed  with  or 
without CD4 depletion.  The mice 
were primed with nothing or with 
an injection of B6 female (Q), B6 
male (Q+  H-Y), or BALB.B fe- 
male (Q + m) spleen ceUs  as indicated 
above each panel.  3  wk (a-d)  or 
12 wk later (e-h),  their spleen cells 
were stimuhted in vitro with ]36 fe- 
male  or aUogeneic A.Tla  b stimu- 
lators and tested for anti-Qal lytic 
activity on B6 female targets,  for 
allo-activity on A.Tla  b targets, and 
for nonspecific lysis on syngeneic 
B6.Tla' female targets. Titration of 
effectors, shown as responder dilu- 
tion, begins with a maximum re- 
sponder  to target  (R/T) ratio  of 
100:1 (a-d) and  133:1 (e-h). 
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depended on T  helper cells, we chose this system to study 
the effect of delivering antigen to CTL precursors in the ab- 
sence of help. 
Three Tests  for Peripheral Tolerance 
To look for evidence of tolerance induction, we primed 
B6  a mice with Qal  b under three sets of conditions, each de- 
signed to deliver signal one in the absence of signal two. (Set 
1)  We  immunized B6  ~ females  with  cells  bearing  Qal  b 
without carrier  antigens. (Set 2) We depleted the mice of 
CD4 + cells before immunizing with Qal  b plus a carrier. 
(Set 3) We immunized B@ male mice with Qal  b plus H-Y, 
a carrier  to which males  are tolerant. 
The mice were then rested for various periods of time, reim- 
munized with ceUs bearing Qal  b plus a known effective car- 
rier, and tested 2 wk later for their ability to generate CTL 
in vitro. 
Set I: Priming with Qal  in the Absence of a Carrier Antigen 
Leads to Permanent Unresponsiveness 
To test the effect of immunizing with cells bearing Qal 
alone, we primed mice with B6 female (Fig. 2, g-h) or male 
calls (d-f), or left them unprimed (a-c), boosted them with 
B6 female (Q), male (Q+H-Y),  or BALB.B (Q+m) cells, 
and tested for their ability to generate CTL responses.  As 
usual, mice that had been injected once responded ortly if 
immunized with carrier-linked  Qal  (Fig.  2,  b and c), and 
all the mice primed with Qal+ H -Y produced CTL regard- 
less of the boosting antigen, but mice that had been prein- 
jected with ceils bearing Qal in the absence of a carrier (Fig. 
2, g and h) were unresponsive to any further challenge with 
Qal. The lack of response was antigen specific, since the mice 
responded well to the carriers used in the boosting immuni- 
zations (e.g.,  H-Y and BALB minors). Thus, the initial in- 
jection is crucial.  If Qal is given with a carrier,  the mice 
are primed. If it is given without a carrier, the mice are ren- 
dered tolerant and no amount of help later will rescue the 
response. 
Qal Alone Also Tolerizes Thymocytes.  Since a proportion 
of mature thymocytes are fully immunocompetent (45, 46), 
we asked whether their responses would be the same as those 
of peripheral cells. Fig. 3 shows that thymic CTL behaved 
like those from the spleen.  They were not primed to Qal 
by cells bearing only a Qal difference (Pig. 3 a), they did 
respond to cells bearing carrier-linked Qal (b and c), and they 
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Figure 2.  Mice immunized with Qal alone become unresponsive.  (~p) The titrated responses (maximal  Ik/T is 100:1) of individual  B6= female 
mice tested in two experiments;  and (bottom) a summary of 54 mice, tested in 20 experiments.  B6  a female mice were left unprimed or were primed 
with B6 male (Q+H-Y), or female spleen cells (Q). 3 wk later, they were boosted in vivo against B6 female, B6 male, or BALB.B (Q+m) as indicated 
above each panel.  2 wk later, their spleen cells were stimulated  in vitro with BALB.B (Q+m) and tested for lysis on B6 female cells (Q alone) and 
BALB.B female (Q+m) targets,  or stimulated  and tested against H-Y (B6  = male). Each point in the summaries represents the specific ])'sis generated 
by an individual  mouse at an K/T ratio of 30-40:1,  and the thin lines to the hft of each group indicate the mean  +  2 SEM. Differences between 
the groups were evaluated by student's  t test. For Qal, groups a and g differ from b, and h differs from c at p < 0.001. The BALB.B and H-Y responses 
do not differ significantly. Lysis of B6  a female targets  never exceeded 3% of the lysis seen on specific targets.  About one third of the mice do not 
respond  to H-Y. This is not unusual  as H-Y is a minor antigen to which mice of most haplotypes  do not respond  and,  even in responsive strains, 
many individuals  give weak  responses which are easily competed by other antigens  (44). 
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Figure 3.  Thymocytes behave like 
spleen cells. These are the thymo- 
cyte responses of mice depicted in 
Fig. 2, a-c, andg and h, stimulated 
and tested as in Fig. 2, except that 
the cultures  contained  10%  CAS. 
Maximal R/T ratio  for the titra- 
tions is 300:1, and the summaries 
are  shown  at  an  R/T  ratio  of 
100-300:1. For Qal, groups a and 
g differ from bbyp = 0.00001, and 
h differs fromc byp = 0.002. Lysis 
of  B6"  female  targets  never  ex- 
ceeded  15%  of the lysis seen  on 
specific targets. 
were turned off by prepriming with antigen in the absence 
of a carrier  determinant (g and h). 
Because small numbers of peripheral T cells, especially ac- 
tivated T  cells, can circulate through the thymus (47, 48), 
we thought that the thymic responses might be due to recir- 
culating activated peripheral CTL rather than activated thymo- 
cytes.  To distinguish between these two possibilities,  we 
studied the kinetics of tolerance induction. We first injected 
mice with B6 female cells (Q), and then, to see how quickly 
tolerance became entrenched, injected them later with B6 
male cells (Q+H-Y). Fig. 4 shows that, in the spleen, toler- 
ance induced by female cells was completely reversed by coin- 
jection of male cells (time 0). By day 2, injection of male 
cells rt~.-ued only 30% of the response, and by day 4 the spleens 
were >95 % unresponsive.  Tolerance occurred slightly faster 
in the thymus, suggesting that both newly arising thymo- 
cytes and any recircuhting peripheral cells were tolerized there. 
Had the activity in the thymus been due to recirculating T 
cells previously activated (or tolerized) in the periphery, toler- 
ance should have appeared later in the thymus than in the 
spleen. Thus, thymocytes specific for Qal follow the same 
rules as peripheral T  cells. They are able to be activated in 
the presence of a helper determinant and are tolerizable  in 
its absence. 
Surprisingly, the tolerant state lasted for 7 mo. Although 
such a durable state of tolerance in nonthymectomized mice 
suggested that the injected B6 female cells had established 
some level of chimerism, we could not detect them in spleen, 
thymus, or lymph nodes by FACS  |  analysis, by staining of 
tissue sections with anti-Qal sera, or by injecting cells .la- 
beled with FITC or StCr. Nevertheless,  mice injected with 
mitomycin C-treated cells were only unresponsive to Qal 
for a few days, suggesting that long-lasting tolerance requires 
the persistence  of at least some of the tolerizing cells. 
The Induced  State of Unresponsiveness  Is Not Simply the Re- 
sult ofThym/c ~/eranca  Suppose that immunizing  with signal 
one alone were a nonevent, having no effect on peripheral 
CTL. If virgin CTL had a fairly short lifespan, they would 
soon die and, by the time we challenged the mice, the pe- 
ripheral pool would consist of ceUs that had been immature 
thymocytes at the time of the first inoculation. The tder- 
ance we measured in the periphery could therefore simply 
reflect the normal path of thymic tolerance induction, rather 
than a direct effect on the mature peripheral CTL population. 
To test this possibility, we thymectomized a group of adult 
mice, waited 1 mo for the periphery to stabilize,  and im- 
munized them with Qal. Fig. 5 shows that these CTL can 
be as effectively immunized as those of normal mice by B6 
male and paralyzed by B6 female cells. Thus, this form of 
tolerance  induction operates  on  mature  peripheral  CTL 
precursors. We conclude that CTL in the spleen, any periph- 
eral cells circulating through the thymus, and newly arising 
thymocytes  can all be paralyzed in the same way and at about 
the same time. 
Set 2: Removing T Helper Ceils Generates Tolerogenic  Conditions 
This experimental group was designed to ask whether car- 
rier antigens mediated their effect through CD4 + T helper 
cells or whether they altered presentation of Qal to the killers 
themsdves. We tested this by giving carrier-free (tolerogenic) 
and carrier-associated (immunogenic)  Qal to mice from which 
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Figure 4.  Kinetics of tolerance  in- 
ductinn. B6' female mice were in- 
jected with spleen  cells at time 0 and 
again on the days indicated.  15 d 
after  the  second  injection,  their 
spleen cells were cultured with B6 
female stimulators and assayed for 
Qal-specitic lysis as in Fig. 1. R/T 
is 133:1  for the splenocytes  and 300:1 
for the thymocytes. 
the CD4 § T helper cells had been temporarily removed. We 
injected mice twice, 24 h apart, with mAbs to CD4, and 
primed them  12  h  later  with  B6  female (Qal)  or  male 
(Qal+ H-Y) cells. 12 wk later,  when the CD4 + cells had 
recovered, we injected a mix of cells carrying Qal plus var- 
ious carriers.  Any remaining functional CTL should now, 
surrounded by T  helper cells and carrier antigen, be easily 
immunized. 
We found that mice immunized during the depleted period 
became unresponsive, whether they were primed with carrier- 
flee (Fig. 6 d) or carrier-linked (e) Qal. This was not simply 
due to temporary removal of CD4 + cells, because mice that 
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Figure 5.  Tolerance  induction  in 
adult thymectomyzed mice. 6-wk- 
old B6= female mice were thymec- 
tomized  or left  untreated  (Normal). 
1  mo later,  some of the thymec- 
tomized mice were primed with B6 
female ceils (Q), and 3 wk later, all 
the mice were boosted with 136 male 
(Q+H-Y).  2 wk after boosting, 
their spleen cells  were cultured with 
B6  female or aliogeneic BALB/c 
stimulators and tested for cytotoxic 
activity on B6 and BALB/c targets, 
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Figure 6.  An immunogenic sig- 
nal is tolerogenic in the absence of 
T  helper  cells.  B6=  female  mice 
were either treated with anti-CD4 
mAbs  (c-e)  or  not  (a  and  b)  and 
primed with B6 female (Q) or male 
(Q+H-Y)  spleen cells as indicated 
above each panel.  The mice were 
boosted with a mix of 10  7 each B6 
male, BALB.B female (Q+ minors), 
and B6= (H-Y)  male cells.  3  wk 
later, the spleen cells were cultured 
and  tested  as  in Fig.  2.  Maximal 
R/T for the titrations is 100:1  for 
the B6 and BALB.B responses and 
133:1  for  H-Y.  Summaries  are 
shown at an R/T of 33-133:1. For 
Qal, a differs from b at p  <0.001, 
and d and e differ from c by p  = 
0.04  and p  =  0.01.  For  H-Y,  e 
differs from c by p  =  0.015.  For 
BALB.B,  there  are  no  significant 
differences. 
were not immunized during the depleted period did produce 
CTL (Fig.  6 c), though slightly less than controls, and all 
the mice responded to the BALB.B minors (Q+m). Fig. 6 e 
shows that depleted mice primed with male cells also failed 
to generate CTL to H-Y, a finding indicating that tolerance 
induction in the absence of help is not found only for the 
medial antigen Qal but also extends to more typical, MHC- 
restricted minor antigens. 
In the thymus, CD4 + cells were coated but not removed 
by anti-CD4 mAbs. Nevertheless, Fig. 7 shows that thymic 
CTL were also turned off if immunized during the period 
of treatment (d and e). So, it appears  that helper cells need 
not be deleted; impairing their activation is enough to pre- 
vent the delivery of help and induce tolerance. 
Thus, an injection of carrier-linked Qal, which is immuno- 
genic in  the presence of help from CD4 + cells,  becomes 
tolerogenic in its absence. From this, we concluded that car- 
tier antigens do not directly affect CTLs by altering the struc- 
ture or tissue distribution of Qal, but act indirectly through 
CD4 + T  helper cells. 
Set 3: Tolerance of the Carrier Antigen Neutralizes  Its Efficacy 
Two possibilities  were left. Either carrier-specific helper 
cells could assist Qal-specific CTL, or the carrier altered the 
expression or processing of Qal itself so that it was effec- 
tively presented by class II molecules to helpers specific for 
Qal peptides (49).  By taking advantage of the natural self- 
tolerance that male mice have for H-Y, we were able to dis- 
tinguish between these two. We assumed that, ifH-Y exerts 
its effect through H-Y-specific helper cells, it should be use- 
less in males. However, if its effect were to alter Qal presen- 
tation to Qal-specific helper cells, then B6  a males should re- 
spond to B6 male cells (12,  50). 
Fig.  8 shows that B6  a males behave essentially like their 
sisters. They do not make strong primary CTL to Qal (b) 
and can be primed by carrier-linked Qal (c). But, unlike fe- 
males, males do not respond if the only available carrier is 
H-Y  (d), in fact they are tolerized (e). Since the presence 
of H-Y does not inhibit the carrier effect of BALB minors 
(c), the tolerogenic property of male cells is unlikely to be 
due  to  dominant  suppression,  but  rather  to  the  lack  of 
H-Y-specific helper T  cells.  Thus,  the carrier effect is due 
to the independent recognition of the carrier antigens by T 
helper cells and not to an indirect effect on the presentation 
of Qal  itself. 
The  Tolerizing Effect Is Not Due to  Thy-1 §  Veto Cells 
Since Qal is a class I antigen, albeit a rather untypical one, 
expressed by activated T cells; since activated T cells are able 
to migrate to the thymus (48) and activated CD8 § T VETO 
cells can turn off CTL responses against their own MHC 
class I molecules (51); since the tolerizing effect can some- 
times be reversed by adding class II differences (helper deter- 
minants?) to  the VETO cells  and reinstated by removing 
CD4 + T helper cells (52), we considered the possibility that 
VETO cells (53) were the APC responsible for tolerance in- 
duction to Qal. 
To test this we first found the minimum tolerizing and 
immunizing doses of Qal + spleen cells (Fig.  9). Though as 
few as  10  s male (Q+H-Y)  cells  were enough  to  prime, 
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Figure 7.  When Th cell activa- 
tion is prevented,  thymic CTL are 
inactivated by signal one. These are 
the thymocyte responses of the mice 
described  in  Fig.  6.  They  were 
stimulated  and tested as in Fig. 6, 
except that the cultures  contained 
10%  CAS. Maximal R/T for the 
titrations is 225:1 for Qal and minor 
responses, and 300:1 for H-Y. Sum- 
maries  are  shown  at  an R/T  of 
75-300:1.  For Qal, a differs from 
b by p  =  0.00002,  d and e differ 
from c byp = 0.008 andp  =  0.03, 
respectively. For H-Y, e differs from 
cbyp = 0.2andfrom bbyp = 0.01. 
tolerance induction required 100-fold more female (Q) cells 
(not surprising since the vast majority of specific CTL must 
be inactivated). Fig. 10 shows that Thy-1- female cells (Q) 
induced tolerance as effectively as untreated cells in both spleen 
and thymus, and Thyol-  male cells (Q+H-Y)  were actu- 
ally more effective at priming. Comparing Figs.  9 and 10, 
we see that our lowest dose of Thy-1- female cells contained 
40-fold fewer T  cells than the minimum tolerizing dose of 
untreated cells.  Thus, Thy-1 + cells had little effect on the 
induction of tolerance or immunity to Qal. Although some 
NK  precursors  in  bone  marrow  are  Thy-1-  (54),  most 
splenic VETO cells (T and NK cells) are Thy-1 + (55). From 
this, we conclude that tolerance to Qal after an injection of 
B6 female cells is unlikely to be due to VETO cells but rather 
to recognition of antigen in the absence of help. 
Recapitulation 
From these results, we conclude that: (a) both thymocytes 
and peripheral CTL  specific for Qal  need help from CD4 + 
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Figure 8.  H-Y does not generate 
signal  two in male mice.  B6  = fe- 
male or male mice were left un- 
primed or were immunized with B6 
male (Q+H-Y). 3 wk later, some 
of  the  mice  were  boosted  with 
BALB.B male as  indicated  above 
each panel. 2 wk later, their spleen 
cells and  thymocytes  were stimu- 
lated as in Figs. 2 and 3 and tested 
on  B6  (Q)  or  BALB.B female 
(Q+m)  targets.  Maximal R/T is 
100:1  for  spleen  and  300:1 for 
thymocytes. 
559  Guerder and Matzinger t st injection  Q  Q+H-Y 
2  nd injection  Q+H-Y  none 
% specific 
lysis 
￿9 
0-  %  O 
i  i  i 
spleen 
60-  ￿9  O/ 
10-  ~  O 
I  I  f  I  i  i  i 
10  4  10  5  10  6  10  7  10  4  10  5  10  6 
thymus 
# of cells in 1  st injection 
Figure 9.  Titration of the number of spleen cells needed to prime or 
tderize to Qal. The mice were primed with various numbers of B6 female 
(Q) or male (Q+H-Y) cells. To test  for tolerance,  mice injected with 
Q-bearing cells were reinjected 2 wk later with Q+H-Y. 2 wk later, all 
the mice were stimulated  and tested on B6 female targets  as in Figs. 2 
and 3. Each point represents  the activity of an individual  mouse at the 
P,/T at which control responses dropped off the plateau: 133:1 for spleen 
and 33:1 for thymus. 
T cells in order to be activated. (b) They can receive this help 
from T cells specific for other determinants (carriers) present 
on the immunizing cells. (c) In the absence of help, whether 
caused by lack of a carrier determinant or lack of T  helper 
cells,  recognition of Qal  is a tolerogenic event. 
We found that: (a) Qal is not unique; H-Y-specific CTL 
were also tolerized in the absence of help. Though this finding 
contrasts with a recent claim for the helper independence of 
H-Y-specific CTL in transgenic mice (4), it agrees with ear- 
lier studies showing that  help was required (56).  (b)  The 
tolerant state was completely antigen specific; CTL to BALB 
minors were unaffected by injections of Qal,  and responses 
to H-Y  dropped only when male cells were given under 
tolerogenic conditions, i.e., in the absence of T helper cells. 
(c) Removing the carrier antigen and removing T helper cells 
were equally effective ways to induce tolerance. (d) Thymic 
CTL were tolerized when the CD4 + cells were coated but 
not depleted by anti-CD4 mAbs. Thus, as Waldmann (57) 
suggested, it may not be necessary to physically remove the 
helpers. If they can be prevented from responding, whether 
or not they themselves become tolerant in the process (58), 
the lack of help results in tolerance of CTL. 
Taken together, our results confirm that the thymus is not 
the only site of tolerance induction, nor are immature thymo- 
cytes the only tolerizable cells. We have shown here that ma- 
ture peripheral CTL are tolerized in the absence of help. Such 
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Figure 10.  VETO cells are not 
required  for  tolerance  induction. 
The mice were  primed  with  107 
untreated  B6 female  (Q) or male 
(Q + H-Y) spleen cells (containing 
30%  and  34%  Thy-1 +  cells, 
respectively) or 5  x  106 to 2  x  107 
depleted  (T-)  female  or  male 
spleen cells (containing 0.5% and 
2.5%  Thy-1 + cells,  respectively). 
5 d later, they were boosted with 
107  BALB.B female  (Q+m)  and 
B6~ male calls (H-Y),  and  2 wk 
later, their spleen ceils were stimu- 
lated  and  tested  on  B6  female 
targets.  Numbers of Thy-1 + con- 
taminating  cells in the primary in- 
ocula are given to the right of each 
curve.  R/T  ratios  were 33:1 for 
spleen and 75:1 for thymus. Lysis of 
B6' female targets  was  1-3%  for 
spleen and  1-17%  for thymus. 
560  T  Cell Tolerance in the Periphery a peripheral fail-safe mechanism can consistently reestablish 
self-tolerance in the face of several types of potentially au- 
toreactive T  cells. 
Discussion 
These results split CTL activation into three stages. In stage 
one, the CTL precursor, like a B cell, advances to a critical 
point and waits for help. If help is not received within about 
24 h (Fig. 3, and 59, 60), the CTL is shut down, but if help 
arrives it moves to the second stage and becomes fully acti- 
vated, ready for step three, in which it can be triggered to 
lyse a target in the complete absence of help (61,  62).  Al- 
though activation (steps one and two) and triggering (step 
three) are both consequences of the same external event (an- 
tigen recognition), the difference in helper requirements points 
to a fundamental distinction between the two. The distinc- 
tion is not simply a property of virgin vs.  memory CTL, 
because resting memory CTL are also tolerized by antigen 
in the absence of help (25). Nor is it a property of the APC, 
because the same APC can activate in a helper-dependent 
fashion and be killed in the absence of help (63). The distinc- 
tion must be intrinsic to the intracellular signaling pathways 
themselves such that a second signal is needed to kick a resting 
CTL into cell division, synthesis of the lytic machinery, etc., 
but signal one is enough to trigger activated CTL to kill 
their targets (64).  This distinction between activation and 
triggering may also hold for T  helper cells, where some of 
the second signals necessary to induce I1.2 production from 
resting T cells are not needed for I1.4 (65, 66), which seems 
to be released when an activated T cell (67, 68) is reactivated. 
How is help delivered? Because resting CTL, being MHC 
class II negative, cannot be seen by class II-restricted helpers, 
Keene and Forman (34) suggested that help was delivered 
via secreted I1.2, and that efficient delivery occurred only if 
the CTL and the helper were attached to the same APC. 
An alternative view is that help for CTL is routed through 
the APC rather than supplied directly from helper to killer. 
This is based on Lafferty and Cunningham's (69)  proposal 
that T  cells need costimulatory signals from APCs, on the 
finding that lack of such costimulatory signals leads to toler- 
ance (59),  and on the evidence that T  helpers can activate 
APC to deliver such signals (70,  71). We picture a system 
in which a helper cell binds to an APC and, rather than simply 
secreting II-2 into the surrounding medium, it induces the 
APC to produce costimulatory signals  for naive CTL.  By 
delegating the help function to activated APC,  a single T 
helper would be able to assist many CTL precursors without 
needing to see the antigen at precisely the same time, and 
the activity of a small number of antigen specific helpers could 
be effectively amplified. Help delivered through APC could 
also explain why CTL responses to some viruses are helper 
independent (72).  If a virus were itself able to activate APC 
or if it infected dendritic cells, a cell type that may constitu- 
tively express costimulation (73, 74), CTL responses would 
ensue without the need of CD4 + T  helper cells. 
Last we come to the question of who controls the con- 
trollers. If help is the controlling factor in peripheral toler- 
ance, what governs the activation of helpers? More helpers? 
Cohn (75) suggests that T  helpers also need help (75),  but 
this leaves him with the chicken-egg problem of what cell 
gives signal two to the first helper. There is some evidence 
that helpers may get their second signals  from professional 
APC (76-78).  This would solve the problem of who came 
first but,  since APC present both self and nonself antigens 
(79-81), it does not deal with the maintenance of tolerance. 
B cells may have a role here. Since B cells are the largest popu- 
lation  of class  II ~  cells,  a  newly  emerging  autoreactive 
CD4 + T cell's first antigen encounter would most likely be 
with a B cell.  If mammalian B cells like those of chickens 
(82), cannot deliver costimulatory signals to virgin T cells, 
this encounter would be tolerogenic. Indeed, resting B cells 
can present rabbit Ig to tolerize virgin T cells (83), and fe- 
male mice can be rendered specifically unresponsive to H-Y 
by an injection of purified male B cells (E. Fuchs and P. Mat- 
zinger, manuscript submitted for publication). However, B 
cell presentation cannot account for tolerance to antigens found 
only on nonlymphoid tissues such as skin or liver. Do other 
cell types also have the ability to tolerize virgin T cells? Bowen 
et al. (84) have shown a slow induction of tolerance in mice 
transplanted with thyroid or pancreas from which the APCs 
were removed; Bal et al.  (85) found that antigen presenta- 
tion by APC depleted keratinocytes can turn off antigen- 
specific T cell clones, and the VETO phenomenon is yet an- 
other example of tolerance induction by tissues  (CD8 + T 
cells or NK cells) that are not professional APCs. We wonder, 
in fact, whether some of the studies that have been classed 
as VETO phenomena (52) are not actually cases of presenta- 
tion of signal one without signal two, since tolerance in these 
cases can be reversed by the addition of a carrier antigen. Im- 
munologists may be dealing here with two quite different 
mechanisms (tolerance due to VETO cells and tolerance due 
to antigen presentation in the absence of signal two) that 
sometimes mimic each other. We presume that any cell capable 
of delivering signal  one  (antigen  associated with  MHC) 
without signal two will turn off virgin T  cells.  However, 
since many tissues do not express class II, there must either 
be a small set of peripheral antigens to which T helper cells 
are truly not tolerant or perhaps still more tolerogenic mech- 
anisms to be found. 
Finally,  on a practical note, if the effector T  and B cells 
of the immune system are consistently rendered unrespon- 
sive by signal one in the absence of help, then T helper cells 
are those on which we should concentrate our efforts to achieve 
transplantation tolerance and the reversal of autoimmune dis- 
ease. If helper cells (whether CD4 or CD8) can be reliably 
rendered unresponsive, the rest of the immune system will 
follow. 
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